Fai un esperimento Leonardoda strega chinese clinical oncology impact factor estratto Facciamolo Da
Home - Chinese Clinical Oncology
Journal of Clinical Oncology - Impact Factor, Overall Ranking, Rating, h-index, Call For Paper, Publisher, ISSN, Scientific Journal Ranking (SJR), Abbreviation, other Important Details | Resurchify
The dawn of China biopharma innovation | McKinsey
The dawn of China biopharma innovation | McKinsey
Chinese Society of Clinical Oncology|CSCO
Asia-Pacific Journal of Clinical Oncology - Wiley Online Library
Home - Chinese Clinical Oncology
Home - Chinese Clinical Oncology
State of Cancer Research Around the Globe
Evaluating eligibility criteria of oncology trials using real-world data and AI | Nature
Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China - The Lancet Oncology
Asia-Pacific Journal of Clinical Oncology - Wiley Online Library
Frontiers | TCMIO: A Comprehensive Database of Traditional Chinese Medicine on Immuno-Oncology | Pharmacology
Cancer drug development in China: recent advances and future challenges - ScienceDirect
Archives - Chinese Clinical Oncology
Characterization of the genomic landscape and actionable mutations in Chinese breast cancers by clinical sequencing | Nature Communications
Journal of Clinical Oncology: Vol 39, No 15_suppl
American Society of Clinical Oncology | Choosing Wisely
Chinese Society of Clinical Oncology|CSCO
Asia-Pacific Journal of Clinical Oncology - Wiley Online Library
Peer-reviewed Oncology & Cancer Research Journal | Oncotarget
Six oncology breakthroughs from Mainland China: Takeaways from ASCO 2021 - Clarivate
Chinese Journal of Clinical Oncology
About Annals of Oncology Impact factor: 32.976
Frontiers | In Real Life, Low-Level HER2 Expression May Be Associated With Better Outcome in HER2-Negative Breast Cancer: A Study of the National Cancer Center, China | Oncology